|
|
Advertisement |
 |
|
|
Advertisement |
DCAT Week: Business Development—Networking—Education
DCAT Week is the premier global event for the business of pharmaceutical development and manufacturing (March 20-23 in New York City). Organized by the Drug, Chemical & Associated Technologies Association, its unique model brings together members for high-level strategic meetings with key decision makers, timely educational programs and important networking opportunities.
Learn more
|
|
ADVERTISEMENT
|
|
|
Special Feature |
 |
Pharm Exec’s Brands of the Year 2017 |
In its 11th annual feature, Pharm Exec breaks from the norm to profile five products that are currently shining the spotlight on critical and highly debated aspects of healthcare and R&D
… /Read more/ |
|
|
Advertisement |
Accelerate the launch of your pharma product, while also easing financial and administrative burdens with 3PL Title Model.
Learn more
|
|
Advertisement |
2017 Real-World Evidence Benchmark Survey
Deloitte's 2017 Real-World Evidence Benchmark Survey shows that life sciences companies are making some progress in using RWE but still have opportunities to expand applications across the value chain, consider new channels to access RWD, and improve their overall capabilities.
Explore this research Today!
|
|
Call for Nominations |
|
Advertisement |
Run the Trial You Want: Transform clinical trials with better data collection This paper will focus on the challenges with collecting data required for a protocol and best practices to address them. Learn how to meet the demands of modern trials with modern, cloud based electronic data capture (EDC) systems that enable you to run the trial you want. Sponsored by Veeva Systems
Read it Today!
|
|
|
|
Calendar |
|
|
Advertisement |
How Cents-Per-Mile Programs Jeopardize Your Bottom Line
Do you reimburse your mobile employees based on a cents-per-mile rate? This type of mileage reimbursement program can cost your company, put you at risk of a class-action lawsuit, and incentivize unproductive driving behavior.
Learn how to protect your business.
|
|
|
Advertisement |
Precision Medicine in Immuno-Oncology
The ongoing advances in cancer immunotherapy together with precision medicine may promise a bright future for patients. Learn about the two most common biomarkers in clinical trials that are critical for the drug development process. Sponsored by Covance
Learn more
|
|
|
|
Strategy |
 |
Launch for Long-Term Success |
Is a fast launch the only path to a high-value product? Surprisingly, the answer is no. A study by The Boston Consulting Group looks at why a pharma brand's early sales are not a trusted predictor for total lifetime value—it's about driving waves of growth
… /Read more/ |
|
|
Advertisement |
Talking the Patients' Language – the importance of effective, patient-centered engagement Live Webinar: Tuesday, June 6 at 8:00am EDT
Register now
|
|
|
Industry update |
//Caris Life Sciences (Irving, TX) appointed John Marshall, M.D., as Chief Medical Officer.//Judit H. Nyirady, M.D., M.B.A. joined LEO Pharma (Madison, NJ) as Vice President of Medical Strategy & Scientific Affairs. //Boston Biomedical (Cambridge, MA) appointed Patricia S. Andrews as Chief Executive Officer. //Nativis (Seattle, WA) appointed Dr. Donna Morgan Murray as Chief Regulatory Officer.// |
Advertisement |
Winning the RAT race: A new Center of Excellence to drive development of regenerative medicines
On Demand
Learn more
|
|
|
|
|